Women in the U.K. May Lose Access to Important Breast Cancer Drugs (ContributorNetwork)

[unable to retrieve full-text content]ContributorNetwork - COMMENTARY | The Telegraph reports that the National Institute for Health and Clinical Excellence (NICE) has decided that two drugs used to treat HER2 positive breast cancer are not cost-effective. As a result, it is possible that two drugs, Herceptin and Tykerb -- Tyverb in the U.K. -- may not be available much longer. Both drugs are used in combination with other drug therapies.

Source: http://us.rd.yahoo.com/dailynews/rss/diseases/*http%3A//news.yahoo.com/s/ac/20120217/hl_ac/10972928_women_in_the_uk_may_lose_access_to_important_breast_cancer_drugs

john edwards heart condition mena suvari pretty in pink joyful noise coachella one life to live jeff fisher